Former CDC Directors Urge PEPFAR Reform, Not Dismantling

Eight former directors of the Centers for Disease Control and Prevention have jointly called for the preservation of PEPFAR, the U.S. government's global HIV/AIDS program, pushing back against a State Department proposal they contend would effectively end it.

The Concern Over a June 1 Deadline

According to a joint opinion piece published in STAT News, a State Department plan had been scheduled for implementation on June 1. The former directors argued that allowing the plan to proceed would strip the United States of infrastructure built over several decades to counter infectious disease threats abroad.

Reform Rather Than Elimination

The authors did not oppose scrutiny or adjustment of the program. Their position, as reported by STAT News, was that PEPFAR warrants reform — not elimination. The distinction is significant: the former officials framed the program not merely as a humanitarian effort but as a component of broader disease defense capacity that, once dismantled, would be difficult to rebuild.

PEPFAR, the President's Emergency Plan for AIDS Relief, has operated as one of the largest international health initiatives in U.S. history, focused on combating HIV/AIDS in heavily affected regions. The former CDC directors' intervention reflects concern that structural changes proposed by the State Department go beyond administrative reform and would functionally end the program's operational reach.

A Rare Collective Statement

Joint public statements from multiple former heads of a federal health agency are uncommon, and the decision by eight former CDC directors to co-author the piece signals the degree of concern among some figures in the public health establishment. The opinion, as covered by STAT News, did not offer specific alternative reform proposals but emphasised the value of preserving the program's foundational disease-response infrastructure.

The broader debate over PEPFAR's future touches on questions of foreign aid spending, global health diplomacy, and the long-term costs of withdrawing from established international disease surveillance and treatment networks.